Cited by

• Effects of the antidopaminergic drug veralipride on LH and PRL secretion in postmenopausal women.

  Fioretti P, Cagnacci A, Paoletti AM, Gambacciani M, Soldani R, Mauro GA, Spinetti A, Melis GB. Fioretti P, et al. J Endocrinol Invest. 1989 May;12(5):295-301. doi: 10.1007/BF03349989. J Endocrinol Invest. 1989. PMID: 2549113
• Antiparkinsonian drugs: pharmacological and therapeutic aspects.

  Calne DB, Reid JL. Calne DB, et al. Drugs. 1972;4(1):49-74. doi: 10.2165/00003495-197204010-00004. Drugs. 1972. PMID: 4405376 Review. No abstract available.
• Amplification of LH response to LHRH by dopamine infusion in eugonadal women.

  Pucci E, Franchi F, Kicovic PM, Sgrilli R, Barletta D, Argenio GF, Gasperi M, Bernini GP, Luisi M. Pucci E, et al. J Endocrinol Invest. 1981 Jan-Mar;4(1):55-8. doi: 10.1007/BF03349415. J Endocrinol Invest. 1981. PMID: 6787110
• Plasma growth hormone and insulin response to levodopa and amantadine.

  Kytömäki O, Nousiainen R, Pekkarinen A, Rinne UK, Viljanen M. Kytömäki O, et al. J Neural Transm. 1973;34(2):145-51. doi: 10.1007/BF01244667. J Neural Transm. 1973. PMID: 4722572 No abstract available.
• Subcellular fractionation of hypothalamus and pituitary stalk of the bull. Morphologic study and serotonin-norepinephrine distribution.

  Andreoli V, Ceccarelli B, Cerati E, Demonte ML, Clementi F. Andreoli V, et al. Exp Brain Res. 1970;11(1):17-28. doi: 10.1007/BF00234199. Exp Brain Res. 1970. PMID: 5458714 No abstract available.